Clinical Trials Directory

Trials / Completed

CompletedNCT01970982

Reduced Exposure Study in Smokers Using the Tobacco Heating System 2.2 (THS 2.2) for 5 Days in a Confinement Setting

A Controlled, 3-arm Parallel Group Study to Demonstrate Reduction in Exposure to Smoke Constituents in Healthy Smokers Switching to THS 2.2 or to Smoking Abstinence, Compared to Conventional Cigarettes for 5 Days in Confinement

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
166 (actual)
Sponsor
Philip Morris Products S.A. · Industry
Sex
All
Age
23 Years – 65 Years
Healthy volunteers
Accepted

Summary

The overall goal of the study is to evaluate if the ad libitum use of the Tobacco Heating System 2.2 (THS 2.2) for 5 consecutive days by adult Japanese healthy smokers affects the levels of biomarkers of exposure for selected harmful and potentially harmful constituents (HPHCs) compared to smoking conventional cigarettes (CC) and smoking abstinence (SA).

Conditions

Interventions

TypeNameDescription
OTHERTobacco Heating System (THS 2.2)THS 2.2 ad libitum for 5 days in confinement
OTHERSmoking abstinence (SA)SA for 5 days in confinement
OTHERConventional cigarette (CC)Subject's own preferred brand of CC ad libitum for 5 days in confinement

Timeline

Start date
2013-07-01
Primary completion
2013-12-01
Completion
2014-07-01
First posted
2013-10-28
Last updated
2020-03-12
Results posted
2016-10-17

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01970982. Inclusion in this directory is not an endorsement.